Savara Inc (SVRA) Pre-Tax Margin
- 2017-03-31: Pre-Tax Margin -5543.62%.
- 2016-12-31: Pre-Tax Margin -1218.31%.
- 2016-09-30: Pre-Tax Margin -7171.11%.
Complete source-backed pre-tax margin history.
- Available history
- 2015-12-31 to 2020-12-31
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2017-03-31 | -5543.62% |
| 2016-12-31 | -1218.31% |
| 2016-09-30 | -7171.11% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2020-12-31 | -19305.45% |
| 2016-12-31 | -2820.00% |
| 2015-12-31 | -16664.81% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |